$21.64
-0.79 (-3.52%)
Performance
1D
—
1W
—
1M
—
3M
-6.28%
6M
+68.54%
1Y
+157.62%
YTD
-7.08%
Open$22.46
Previous Close$22.43
Day High$22.75
Day Low$21.64
52W High$26.40
52W Low$6.50
Volume—
Avg Volume1.00M
Market Cap2.41B
P/E Ratio—
EPS$-3.43
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$22.13
Below
SMA 200
$15.14
Above
RSI (14)
36.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
18 analysts
Price Target
+364.4% upside
Current
$21.64
$21.64
Target
$100.50
$100.50
$77.00
$100.50 avg
$121.27
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 328.18M | 374.34M | 841.86M |
| Net Income | -359,987,575 | -369,554,941 | -67,570,170 |
| Profit Margin | -109.7% | -104.2% | -8.0% |
| EBITDA | -412,134,772 | -446,592,943 | -58,220,570 |
| Free Cash Flow | — | — | -41,442,789 |
| Rev Growth | -12.3% | -12.3% | +8.2% |
| Debt/Equity | 0.10 | 0.10 | 0.24 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |